191 related articles for article (PubMed ID: 25631214)
1. Specialist integrated haematological malignancy diagnostic services: an Activity Based Cost (ABC) analysis of a networked laboratory service model.
Dalley C; Basarir H; Wright JG; Fernando M; Pearson D; Ward SE; Thokula P; Krishnankutty A; Wilson G; Dalton A; Talley P; Barnett D; Hughes D; Porter NR; Reilly JT; Snowden JA
J Clin Pathol; 2015 Apr; 68(4):292-300. PubMed ID: 25631214
[TBL] [Abstract][Full Text] [Related]
2. Implementation of the updated NICE haematological cancers (NG47) improving outcomes guidelines across Specialist Integrated Haematological Malignancy Diagnostic Services (SIHMDS) in England: a UK NEQAS LI survey.
Cartwright A; Snowden JA; Whitehouse H; Scott S; Whitby L
J Clin Pathol; 2023 Sep; 76(9):618-623. PubMed ID: 35508367
[TBL] [Abstract][Full Text] [Related]
3. Haematological cancers: improving outcomes. A summary of updated NICE service guidance in relation to Specialist Integrated Haematological Malignancy Diagnostic Services (SIHMDS).
Snowden JA; O'Connell S; Hawkins J; Dalley C; Jack A; Mannari D; McNamara C; Scott M; Shenton G; Soilleux E; Macbeth F;
J Clin Pathol; 2017 Jun; 70(6):461-468. PubMed ID: 28389440
[TBL] [Abstract][Full Text] [Related]
4. The development of haematopathology laboratories: a possible model for other pathology services.
Jack AS; Morgan GJ
J Pathol; 1998 Mar; 184(3):231-3. PubMed ID: 9614372
[TBL] [Abstract][Full Text] [Related]
5. Organisation of neoplastic haematopathology services: a UK perspective.
Jack A
Pathology; 2005 Dec; 37(6):479-92. PubMed ID: 16373228
[TBL] [Abstract][Full Text] [Related]
6. Haematological malignancies: the rationale for integrated haematopathology services, key elements of organization and wider contribution to patient care.
Ireland R
Histopathology; 2011 Jan; 58(1):145-54. PubMed ID: 21261689
[TBL] [Abstract][Full Text] [Related]
7. The development of integrated haematopathology laboratories: a new approach to the diagnosis of leukaemia and lymphoma.
Richards SJ; Jack AS
Clin Lab Haematol; 2003 Dec; 25(6):337-42. PubMed ID: 14641135
[TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness of Reduced Waiting Time for Head and Neck Cancer Patients due to a Lean Process Redesign.
Simons PA; Ramaekers B; Hoebers F; Kross KW; Marneffe W; Pijls-Johannesma M; Vandijck D
Value Health; 2015 Jul; 18(5):587-96. PubMed ID: 26297086
[TBL] [Abstract][Full Text] [Related]
9. Benchmarking in pathology: development of an activity-based costing model.
Burnett L; Wilson R; Pfeffer S; Lowry J;
Pathology; 2012 Dec; 44(7):644-53. PubMed ID: 23149379
[TBL] [Abstract][Full Text] [Related]
10. Estimating implementation and operational costs of an integrated tiered CD4 service including laboratory and point of care testing in a remote health district in South Africa.
Cassim N; Coetzee LM; Schnippel K; Glencross DK
PLoS One; 2014; 9(12):e115420. PubMed ID: 25517412
[TBL] [Abstract][Full Text] [Related]
11. Neonatal screening for inborn errors of metabolism: cost, yield and outcome.
Pollitt RJ; Green A; McCabe CJ; Booth A; Cooper NJ; Leonard JV; Nicholl J; Nicholson P; Tunaley JR; Virdi NK
Health Technol Assess; 1997; 1(7):i-iv, 1-202. PubMed ID: 9483160
[TBL] [Abstract][Full Text] [Related]
12. [Interest in and limitations of economic assessment applied to the evaluation of medical strategies: examples in oncological hematology].
Moatti JP
Therapie; 2001; 56(2):135-8. PubMed ID: 11471364
[TBL] [Abstract][Full Text] [Related]
13. [Workshop - economic governance mechanisms : for Hematology and Oncology].
Strech D; Deh U; Schmitz S; Gürkan I; Ostermann H; Krause SW
Oncol Res Treat; 2015; 38 Suppl 1():3-22. PubMed ID: 25676572
[No Abstract] [Full Text] [Related]
14. Using a Time-Driven Activity-Based Costing Model To Determine the Actual Cost of Services Provided by a Transgenic Core.
Gerwin PM; Norinsky RM; Tolwani RJ
J Am Assoc Lab Anim Sci; 2018 Mar; 57(2):157-160. PubMed ID: 29555005
[TBL] [Abstract][Full Text] [Related]
15. The NHS: failing to deliver on Beveridge's promise?
The Lancet Oncology
Lancet Oncol; 2018 Jan; 19(1):1. PubMed ID: 29304349
[No Abstract] [Full Text] [Related]
16. [Pursuing the triple aim: evaluation of the integrated care system Gesundes Kinzigtal: population health, patient experience and cost-effectiveness].
Hildebrandt H; Pimperl A; Schulte T; Hermann C; Riedel H; Schubert I; Köster I; Siegel A; Wetzel M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Apr; 58(4-5):383-92. PubMed ID: 25652116
[TBL] [Abstract][Full Text] [Related]
17. Use of a United States-based laboratory as a hematopathology reference center for a developing country: logistics and results.
Deetz CO; Scott MG; Ladenson JH; Seyoum M; Hassan A; Kreisel FH; Nguyen TT; Frater JL
Int J Lab Hematol; 2013 Feb; 35(1):77-81. PubMed ID: 22938565
[TBL] [Abstract][Full Text] [Related]
18. Burn service costing using a mixed model methodology.
Duncan RT; Dunn KW
Burns; 2020 May; 46(3):520-530. PubMed ID: 32199624
[TBL] [Abstract][Full Text] [Related]
19. How much does a diabetes out-patient appointment actually cost? An argument for PLICS.
Grant P
J Health Organ Manag; 2015; 29(2):154-69. PubMed ID: 25800330
[TBL] [Abstract][Full Text] [Related]
20. Funding Cancer Quality Improvement: Payer's Perspective.
Schumacher H
J Oncol Pract; 2015 May; 11(3):180-1. PubMed ID: 25804984
[No Abstract] [Full Text] [Related]
[Next] [New Search]
